Document Detail

Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat.
MedLine Citation:
PMID:  2105452     Owner:  NLM     Status:  MEDLINE    
The profile of hepatic microsomal cytochrome P450 expressed in the male and female rat was dramatically altered by streptozotocin-induced diabetes. In the diabetic male, P450 forms IIC11, IIC13, IIA2, and IIIA2 were suppressed and forms IIA1 and IIC12 were induced to the levels observed in the immature male rat. A 6- to 8-fold induction of P450 IIE1 was detected in both male and female diabetic rats. A member of the P450 IIIA family was also induced in the diabetic female rat. Accompanying the change in P450 profile in the diabetic male rat was reduction in circulating testosterone and tetraiodothyronine concentrations and a sharp diminution of the normally pulsatile pattern of growth hormone secretion. In contrast to the male rat, the growth hormone secretion pattern in the diabetic female rat was unchanged from control. The hormone and P450 profiles detected in the diabetic male rat suggest a reversion to an immature physiological state. Testosterone replacement treatments carried out for 2 weeks slightly but significantly affected the suppression of P450 IIC11 and reversed the changes in P450 IIA2, IIIA2, and IIC12 in the diabetic male, without altering the suppressed state of growth hormone secretion. However, 1 week of human growth hormone, administered intravenously every 4 hr to diabetic male rats, failed to significantly reverse the diabetes-induced changes in hepatic cytochromes P450, in particular forms IIC11 and IIE1, despite the presence of an episodic plasma hGH profile. An induction of P450 IIE1 in diabetic female rats, without a reduction in growth hormone secretion, suggests that its induction in diabetes in both sexes is not related to changes in growth hormone. In addition, the results of testosterone treatment on the expression of IIC12, IIA2, and IIIA2 in the diabetic male rat suggest a regulatory role for this hormone that does not involve the pituitary secretion of growth hormone. However, the lack of effect of human growth hormone treatment in the diabetic male on levels of individual P450 forms indicates that in diabetes there may be a change in the ability of the male rat hepatocyte to respond to a somatic signal, possibly as a result of the changes in other hormone factors.
K E Thummel; J B Schenkman
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Molecular pharmacology     Volume:  37     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  1990 Jan 
Date Detail:
Created Date:  1990-02-23     Completed Date:  1990-02-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  119-29     Citation Subset:  IM    
University of Connecticut Health Center, Farmington 06032.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Weight
Cytochrome P-450 Enzyme System / metabolism*
Diabetes Mellitus, Experimental / enzymology*
Growth Hormone / pharmacology*
Growth Hormone-Releasing Hormone / pharmacology
Insulin / pharmacology
Microsomes, Liver / enzymology
Testosterone / pharmacology*
Grant Support
Reg. No./Substance:
11061-68-0/Insulin; 58-22-0/Testosterone; 9002-72-6/Growth Hormone; 9034-39-3/Growth Hormone-Releasing Hormone; 9035-51-2/Cytochrome P-450 Enzyme System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lipid and apoprotein modifications in body builders during and after self-administration of anabolic...
Next Document:  Stoichiometry of G protein subunits affects the Saccharomyces cerevisiae mating pheromone signal tra...